We are live on ! Find out more
CRDF icon

Cardiff Oncology

90 hedge funds and large institutions have $176M invested in Cardiff Oncology in 2021 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 23 increasing their positions, 24 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

113% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 15

23% more funds holding

Funds holding: 7390 (+17)

5.65% more ownership

Funds ownership: 64.99%70.64% (+5.7%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

4% less repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 24

10% less call options, than puts

Call options by funds: $2.11M | Put options by funds: $2.35M

21% less capital invested

Capital invested by funds: $223M → $176M (-$46.7M)

Holders
90
Holders Change
+17
Holders Change %
+23.29%
% of All Funds
1.57%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
32
Increased
23
Reduced
24
Closed
15
Calls
$2.11M
Puts
$2.35M
Net Calls
-$239K
Net Calls Change
+$4.54M
Name Holding Trade Value Shares
Change
Change in
Stake
Rockefeller Capital Management
76
Rockefeller Capital Management
New York
$5K -$2.99K -353 -29%
EWA
77
Evolution Wealth Advisors
Florida
$5K
EBA
78
Eagle Bay Advisors
New York
$3K +$2.88K +339 New
AF
79
Allworth Financial
California
$1K -$7.28K -858 -90%
Bessemer Group
80
Bessemer Group
New Jersey
$1K
NFSG
81
Newbridge Financial Services Group
Florida
$1K
TWA
82
TCI Wealth Advisors
Arizona
$1K
US Bancorp
83
US Bancorp
Minnesota
$1K +$399 +47 +43%
EVM
84
Eaton Vance Management
Massachusetts
$1K +$1.18K +139 New
GEA
85
Glen Eagle Advisors
New Jersey
$333
AIG
86
American International Group
New York
$135 +$172K +20,261 New
PAMU
87
Pictet Asset Management (UK)
United Kingdom
-$5.39M -581,907 Closed
Millennium Management
88
Millennium Management
New York
-$2.99M -322,962 Closed
FM
89
Frazier Management
Washington
-$2.72M -293,500 Closed
HF
90
HRT Financial
New York
-$2.63M -283,885 Closed
Fidelity Investments
91
Fidelity Investments
Massachusetts
-$1.39M -149,780 Closed
SCM
92
Soleus Capital Management
Connecticut
-$395K -42,684 Closed
MIFH
93
Migdal Insurance & Financial Holdings
Israel
-$306K -33,064 Closed
Jane Street
94
Jane Street
New York
-$229K -27,057 Closed
PFS
95
Prospera Financial Services
Texas
-$247K -26,650 Closed
LP
96
LMR Partners
United Kingdom
-$216K -23,332 Closed
Ensign Peak Advisors
97
Ensign Peak Advisors
Utah
-$205K -22,123 Closed
BAM
98
Blueshift Asset Management
New Jersey
-$134K -14,487 Closed
MS
99
Maven Securities
Jersey
-$51K -5,484 Closed
VFA
100
Valeo Financial Advisors
Indiana
-$21K -2,250 Closed

CRDF Hedge Fund Activity: Q2 2021 in Review

90 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Cardiff Oncology (CRDF) for Q2 2021, worth a combined $176M — down 21% from $223M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new CRDF positions and 15 closed out — a net gain of 17 holders — while 23 added to existing stakes and 24 trimmed.

The largest buyer was BlackRock, adding an estimated $15.5M. The largest seller was Corriente Advisors, cutting an estimated $11.9M.

  • 90 institutional investors held Cardiff Oncology (CRDF) as of Q2 2021, up from 73 in Q1 2021.
  • Funds reported $176M of Cardiff Oncology stock for Q2 2021, down 21% quarter-over-quarter.
  • 32 funds opened new Cardiff Oncology positions in Q2 2021 and 15 closed out, a net change of +17 holders.
  • The largest Cardiff Oncology buyer in Q2 2021 was BlackRock, an estimated $15.5M added.
  • The largest Cardiff Oncology seller in Q2 2021 was Corriente Advisors, an estimated $11.9M sold.

Based on aggregated 13F filings for Q2 2021.